News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Sanofi (SAN.PA) Approached AstraZeneca PLC (AZN)'s Soriot For CEO Role     10/30/2014
AstraZeneca PLC (AZN) Wins FDA Approval For Two-In-One Diabetes Pill     10/30/2014
Chimerix, Inc. (CMRX) To Raise $105 Million To Finance Ebola Drug Trials     10/30/2014
Boston’s Rhythm Withdraws $86 Million IPO Citing Acquisition Agreement With Actavis (ACT)     10/30/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care     10/30/2014
Express Scripts Inc. Says AbbVie (ABBV)'s Drug Could Displace Gilead Sciences, Inc. (GILD)'s Sovaldi On Formulary     10/30/2014
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS)     10/30/2014
Novo Nordisk A/S (NVO) More Mindful On Timing Of U.S. Tresiba Launch     10/30/2014
Arena Pharmaceuticals, Inc. (ARNA) Skimps On Data Disclosure From Weight-Loss Combo Study: Analyst     10/30/2014
FortuneRock Raises $24 Million for Protein Drug Development     10/30/2014
Sanofi (SAN.PA) Ousts CEO After Clash Over Strategy     10/29/2014
Under Immense Pressure, Amgen (AMGN) Outlines Strategy     10/29/2014
Novo Nordisk A/S (NVO) To Hire 90 In New Hampshire     10/29/2014
Abbott Laboratories (ABT) Pays $250 Million For Menlo Park Startup Topera     10/29/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears"     10/29/2014

Featured Stories
When Will Biosimilars Impact The U.S. Market?     10/30/2014
Dear Sanofi (SAN.PA): Firing CEO Was A Huge Mistake     10/30/2014
Sanofi (SAN.PA): What About Genzyme Corporation (GENZ)?     10/30/2014
The Reasons Why Garabedian Remains The Best CEO To Head Sarepta Therapeutics (SRPT)     10/30/2014
Saliva May Reveal Deadly Diseases Early Enough To Treat Them, University of California, Los Angeles (UCLA) Scientists Report     10/30/2014
Dozens Of Genes Associated With Autism In New Research, University of California, San Francisco (UCSF) Reveals     10/30/2014
Synthetic Milk Could Be In Your Fridge By 2017, Muufri Reveals     10/30/2014
Certain Skull Shapes And Other Science Behind Carrying A Tune     10/30/2014
Contamination Likely Explains "Food Genes In Blood" Claim, University of Michigan Study     10/30/2014
BioPharm Executive: 5 Reasons To Hate Biotech     10/29/2014
The 14 Best-Performing CEOs In Biotech     10/29/2014
3 Daily Servings Of Milk Linked To Higher Mortality In Women, Uppsala Universitet Study     10/29/2014
Is Violent Crime In Some People's Genes? Karolinska Institute Study     10/29/2014
Don’t Bet On Stinginess To Keep Stress Low, Queensland University of Technology Study     10/29/2014
Tea And Citrus Products Could Lower Ovarian Cancer Risk, New University of East Anglia Research Finds     10/29/2014

More News
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older     10/30/2014
TWi Pharmaceuticals, Inc. Receives U.S. FDA Approval On Generic Donepezil Hydrochloride Tablets USP, 23 Mg, Its Fifth ANDA From U.S. FDA     10/30/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older     10/30/2014
Lannett Company, Inc. (LCI) Receives FDA Approval For Letrozole Tablets USP 2.5 mg     10/30/2014
Helsinn Group Release: New Data On Fatigue From ROMANA 1, A Pivotal Phase III Study Of Anamorelin In Advanced NSCLC Patients With Cachexia Presented At 2014 Chicago Multidisciplinary Symposium In Thoracic Oncology     10/30/2014
Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial For SD-809 In Tardive Dyskinesia     10/30/2014
Immunomedics, Inc. (IMMU) Provides Update On Phase 2 Study Of Isactuzumab Govitecan In Patients With Diverse Metastatic Solid Cancers     10/30/2014
Recro Pharma (REPH) Announces Dosing Of First Patient In Phase 2 REC-14-013 Clinical Trial Of Dex-IN For Treatment Of Acute Pain On Day 1 Following Surgery     10/30/2014
GW Pharmaceuticals Commences Phase 2/3 Clinical Trial Of Epidiolex® As A Potential Treatment For Epilepsy In Dravet Syndrome     10/30/2014
Ultragenyx Pharmaceuticals (RARE) Granted EU Orphan Drug Designation For KRN23 For The Treatment Of X-Linked Hypophosphatemia     10/30/2014
Neurocrine Biosciences, Inc. (NBIX) Receives Breakthrough Therapy Designation For NBI-98854 In Tardive Dyskinesia     10/30/2014
AnaMar AB Reports Top-Line Results From Exploratory Phase 2a Study Of AMAP102 And Provides Corporate Update     10/30/2014
GW Pharmaceuticals Commences Phase 2/3 Clinical Trial Of Epidiolex® As A Potential Treatment For Epilepsy In Dravet Syndrome     10/30/2014
Kiadis Pharma's Lead Product ATIR™ Granted Orphan Drug Designation By European Medicines Agency For The Treatment Of Acute Myeloid Leukemia     10/30/2014
NovoCure Ltd. Enrolls First Patient In A Pilot Study Of Tumor Treating Fields (TTFields) Together With Paclitaxel For The Treatment Of Recurrent Ovarian Cancer     10/30/2014
Hemispherx Biopharma (HEB) Reports New Evidence -- Based Potential Of Ampligen® Against Ebola Virus Disease (EVD)     10/30/2014
FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M™     10/30/2014
Advaxis, Inc.'s ADXS-Cher2 Immunotherapy Demonstrates T-Cell Immune Response In Data Analysis From Canine Osteosarcoma Study     10/30/2014
Caris Life Sciences Release: Large Studies Show Caris Molecular Intelligence™ Identifies Targets With Therapeutic Implications To Help Physicians Select Regimens To Manage Patients With Lung Tumors     10/30/2014
Children's Hospital of Philadelphia Release: After Prenatal Detection Of Congenital Heart Disease, Is Fetal Intervention The Optimal Choice?     10/30/2014
ViaDerma, Inc. Lead Product TetraStem Shown Effective In Fighting Staph Infections Including MRSA     10/30/2014
Jennewein Biotechnologie Release: Protection Against Norovirus By Human-Milk-Oligosaccharides     10/30/2014
University of Bath Release: New Research Reveals Fish Are Smarter Than We Thought     10/30/2014
PerkinElmer, Inc. (PKI) Acquires Ceiba Solutions, Inc.     10/30/2014
MediGene AG (MDGEF.PK)'s Licensee Enters Promotion Agreement To Expand Veregen® Product Sales In The United States     10/30/2014
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics     10/30/2014
Medivir AB (MVRBF) And County Councils Conclude Agreement On Olysio®-Based Treatment For Hepatitis C     10/30/2014
Transgenomic, Inc. (TBIO) And University of Melbourne Collaborate To Further Validate Ability Of Multiplexed ICE COLD-PCRTM To Enable Personalized Cancer Treatment     10/30/2014
Lupus Research Institute Awards $1-Million Grants To Discover What Causes Lupus     10/30/2014
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS     10/30/2014
Levolta Pharmaceuticals Receives U.S. Patent For Novel Investigational Therapy For Controlling Osteoarthritis     10/30/2014
Roche Holdings, Inc. Announces Debt Tender Offer     10/30/2014
Ambit Biosciences Announces Expiration Of Hart-Scott-Rodino Waiting Period     10/30/2014
Chimerix, Inc. (CMRX) Announces Commencement Of Public Offering Of Common Stock     10/30/2014
Neptune Technologies & Bioressources Inc. Receives TSX Approval For Normal Course Issuer Bid     10/30/2014
IBM Corporation (IBM) And Cleveland Clinic Use Watson To Advance Genomic Research For Cancer Care Pilot     10/30/2014
Versartis, Inc. (VSAR) Schedules Conference Call To Discuss Plans For Phase 3 Trial For VRS-317 In Pediatric Growth Hormone Deficiency Patients     10/30/2014
TNI BioTech, Through Its Wholly Owned Subsidiary TNI Biotech International Ltd., Announces Start Of A Bridging Trial In Nigeria For HIV/AIDS     10/30/2014
Texas Children's Hospital Part Of First Worldwide Clinical Trial For Epidiolex® In Children With Dravet Syndrome     10/30/2014
Eli Lilly (LLY) Shares Insights From Decade-Long Technology Transfer Experience     10/30/2014
Affinivax Launches Novel Conjugate Vaccine For Global Impact On Infectious Diseases     10/30/2014
Aphena Maryland Completes New Blending Area     10/30/2014
AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp     10/30/2014
Grand Opening Of NxStage Medical, Inc. (NXTM) Kidney Care Oak Brook IL Center     10/30/2014
WuXi PharmaTech Co., Ltd. Launches Representative Office In Israel, Forms Strategic Collaboration With Pontifax     10/30/2014
Array BioPharma, Inc. (ARRY) To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014     10/30/2014
Auxilium Pharmaceuticals (AUXL) Announces Third Quarter 2014 Financial Results     10/30/2014
AMAG Pharmaceuticals, Inc. (AMAG) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014     10/30/2014
Aptose Biosciences To Host Conference Call And Webcast For Four Month Interim Period Ended September 30, 2014     10/30/2014
Ardelyx Inc. (ARDX) To Report Third Quarter 2014 Financial Results On November 6, 2014     10/30/2014
Alnylam Pharmaceuticals (ALNY) To Webcast Conference Call Discussing Third Quarter 2014 Financial Results     10/30/2014
Anika Therapeutics (ANIK) Reports Third-Quarter 2014 Financial Results     10/30/2014
AmerisourceBergen Corporation (ABC) Reports Fourth Quarter And Fiscal Year 2014 Results     10/30/2014
Antares Pharma, Inc. (ATRS) To Host Third Quarter 2014 Operating And Financial Results Conference Call     10/30/2014
Acceleron Pharma To Host Third Quarter 2014 Financial Results Conference Call And Webcast On November 7, 2014     10/30/2014
BioLife Solutions, Inc. (BLFS.OB) To Report Financial Results For Third Quarter 2014 And Provide Business Update On November 6, 2014     10/30/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January - September 2014     10/30/2014
CTI BioPharma Reports Third Quarter 2014 Financial Results     10/30/2014
Cempra Pharmaceuticals, Inc. Reports Third Quarter 2014 Financial Results And Provides Corporate Update     10/30/2014
Cardinal Health, Inc. (CAH) Reports Fiscal 2015 First-Quarter Results     10/30/2014
Cambrex Corporation (CBM) Reports Third Quarter 2014 Financial Results     10/30/2014
Cerulean Pharma Inc. (CERU) To Host Third-Quarter 2014 Conference Call On November 13     10/30/2014
China Biologic Products To Report Third Quarter 2014 Financial Results     10/30/2014
Charles River Laboratories (Massachusetts) Announces Third-Quarter 2014 Results From Continuing Operations     10/30/2014
Endocyte, Inc. (ECYT) Announces Third Quarter 2014 Earnings Conference Call     10/30/2014
Enzymotec To Report Third Quarter Fiscal Year 2014 Financial Results     10/30/2014
Epizyme (EPZM) To Report Third Quarter 2014 Financial Results And Provide Corporate Update On November 6, 2014     10/30/2014
Genocea Biosciences To Announce Third Quarter 2014 Financial Results On November 6, 2014     10/30/2014
Harvard Bioscience Inc. (HBIO) Reports Third Quarter 2014 Results     10/30/2014
Idera Pharmaceuticals, Inc. (IDRA) To Announce Third Quarter 2014 Financial Results And Corporate Update On November 7, 2014     10/30/2014
Incyte Corporation (INCY) Reports 2014 Third-Quarter Financial Results And Updates Shareholders On Key Clinical Programs     10/30/2014
Keryx Biopharmaceuticals (KERX) To Host Conference Call On Third Quarter 2014 Financial Results     10/30/2014
Karyopharm Therapeutics (KPTI) To Report Third Quarter 2014 Financial Results On November 10, 2014     10/30/2014
Minerva Neurosciences, Inc. (NERV) To Host Third Quarter 2014 Financial Results Webcast And Conference Call     10/30/2014
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Third Quarter 2014 Financial Results On November 5, 2014     10/30/2014
Nektar Therapeutics (CA) (NKTR) To Announce Financial Results For The Third Quarter 2014 On Thursday, November 6, 2014, After Close Of U.S.-Based Financial Markets     10/30/2014
Oncothyreon Inc. (ONTY) Announces Third Quarter 2014 Financial Results Conference Call     10/30/2014
Psychemedics Corporation (PMD) Announces Record Revenues     10/30/2014
Pacira Pharmaceuticals, Inc. (PCRX) Reports Third Quarter EXPAREL Revenue Of $50.2 Million And Third Quarter 2014 Results     10/30/2014
Pozen, Inc. (POZN) Announces November 6th Webcast Of Third Quarter 2014 Results     10/30/2014
PHT Corporation Achieves Strong Growth In 3rd Quarter As Demand For Patient-Driven eData Systems In Clinical Research Grows     10/30/2014
PAREXEL International (PRXL) Reports First Quarter Fiscal Year 2015 Results     10/30/2014
Quintiles Reports 3rd Quarter 2014 Results     10/30/2014
ReVance Therapeutics, Inc. (RVNC) To Release Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, November 12, 2014     10/30/2014
Raptor Pharmaceutical Inc. (RPTP) To Hold Third Quarter 2014 Financial Results Conference Call And Webcast On Thursday, November 6, At 4:30 P.M. ET     10/30/2014
Regado Biosciences, Inc. (RGDO) To Provide Third Quarter 2014 Financial Results     10/30/2014
Roka Bioscience, Inc. (ROKA) To Report Third Quarter 2014 Financial Results On November 6, 2014     10/30/2014
Supernus Pharmaceuticals (SUPN) To Host Third Quarter 2014 Earnings Conference Call     10/30/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Third Quarter 2014 Financial Results Teleconference And Webcast     10/30/2014
Transgenomic, Inc. (TBIO) Reports Third Quarter 2014 Financial Results     10/30/2014
Teva Pharmaceutical Industries Limited (TEVA) Reports Third Quarter 2014 Results     10/30/2014
Vical Incorporated (VICL) Reports Third Quarter 2014 Financial Results And Progress In Key Development Programs     10/30/2014
VIVUS Announces Date Of Third Quarter 2014 Update And Financial Results Conference Call     10/30/2014
Verastem, Inc. (VSTM) Reports Third Quarter 2014 Financial And Corporate Results     10/30/2014
ABIVAX Strengthens Executive Management Team With Senior Appointments     10/30/2014
AusBiotech Ltd. Announces New Chairman And Directors     10/30/2014
Affinivax Appoints Frances K. Heller To Board of Directors     10/30/2014
Affinivax Appoints Frances K. Heller To Board Of Directors     10/30/2014
Ciclofilin Pharmaceuticals Appoints Michael Kamdar To Its Board Of Directors     10/30/2014
H. Stewart Parker Joins Impel NeuroPharma’s Board of Directors     10/30/2014
Mapi Pharma Appoints Charles Makin To lead North America Health Economics & Outcomes Research Team     10/30/2014
The National Meningitis Association Applauds FDA Approval Of First Serogroup B Meningococcal Disease Vaccine     10/30/2014
CytRx Corporation (CYTR) Announces Oral Presentation At 2014 Chemotherapy Foundation Symposium     10/30/2014
Isis Pharmaceuticals, Inc. (ISIS) To Present At The Nomura Biotechnology Conference     10/30/2014
Can-Fite BioPharma (CFBI) To Participate In Biotechnology Industry Organization (BIO)-Europe International Partnering Conference     10/30/2014
Navidea Biopharmaceuticals (NAVB) Announces Scientific Presentations Of Results From Lymphoseek® Studies At The European Association Of Nuclear Medicine And European Society Of Surgical Oncology Meetings     10/30/2014
Infinity Pharmaceuticals Inc. (INFI) To Participate In Four Conferences In November     10/30/2014
Loxo Oncology (LOXO) To Present Pre-Clinical Data On LOXO-101 At Upcoming European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium     10/30/2014
Fate Therapeutics (FATE) To Present At Nomura Biotechnology Conference     10/30/2014
Celator Pharmaceuticals, Inc. To Present On Liposome Delivery Systems At 2014 American Association Of Pharmaceutical Scientists Annual Meeting     10/30/2014
Celanese Discusses Innovative Uses For EVA Polymers At AAPS     10/30/2014
Molecular Profiles To Launch US Strategic Alliance At AAPS     10/30/2014
WHEATON® Highlights Unique Products At AAPS 2014 Providing Purpose-Built Solutions For The Pharmaceutical Industry     10/30/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical And Preclinical Data At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics Meeting     10/30/2014
Relypsa, Inc. (RLYP) To Present At Nomura Biotechnology Conference     10/30/2014
Avalanche Biotechnologies (AAVL) To Participate In Nomura's Biotechnology Conference     10/30/2014

Career Tips
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/27/2014
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014
Get A Biotech Job By Thinking Like A Hiring Manager     10/9/2014
7 Deadly Interview Sins     10/9/2014
3 Ways To Uncover A Hidden Job     10/9/2014
3 Crucial Areas To Ask About During The Interview     10/9/2014
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation (LMNX)     9/26/2014
The One Job Search Technique That Eliminates Your Competition     9/25/2014
The Secret To Being The Only Person Applying For the Job     9/25/2014
5 Golden Rules For Negotiating Salary     9/25/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->